Login to Your Account



EU Grants Propel Procarta’s Work on New Antibiotics

By Nuala Moran
Staff Writer

Wednesday, October 2, 2013
LONDON – Procarta Biosystems Ltd. was awarded more than £1 million (US$1.6 million) in two European Union (EU) grants, enabling it to prepare the first of a new generation of antibiotics based on transcription factor decoys for the clinic, and providing a stepping stone to a funding round in which the company aims to raise £10 million.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription